Short description
ImmunArtes is a biotech company innovating vaccines and therapeutics.
Description
ImmunArtes immune evasion mechanisms with increased rates of antibiotic resistance. They develop vaccines and therapeutics that will effectively neutralize MRSA's immune evasion. They provide patients with vaccination against staph infection. They intend to address the bacteria's immune evasion mechanism and demonstrate protection against infection.
Total funding
$$2020202
Sign in for full access
Location
Chicago, Illinois, United States, North America
Founded on
January 1, 2017
Non-profit?
No
Acquired?
No
Employees count
1-10
Investors
Noway Youcantaccess, Blurry Noaccess
Sign in for full access
Founders
Dominique Missiakas, Hwan Keun Kim, Olaf Schneewind